Results 31 to 40 of about 45,205 (210)

Factors Influencing Depression in Korean Men with Androgenic Alopecia

open access: yesIranian Journal of Public Health, 2021
No ...
Jung-Won KIM
doaj   +1 more source

Androgenic alopecia: an entity to consider in adolescence [PDF]

open access: yesBMJ Case Reports, 2017
A 15-year-old healthy adolescent girl went to her physician consultation because she was preoccupied with progressive thinning of her hair since 11 years old. In the last year, she noticed an aggravation, with an excessive hair loss. She does not have hirsutism, acne, asthenia, menstrual irregularities or weight variations.
Rodrigues, M   +3 more
openaire   +3 more sources

Evaluation of Dry Eye in Female Androgenic Alopecia Patients [PDF]

open access: yes, 2023
Materials and methods: Twenty five left eyes of 25 female androgenetic alopecia patients (Group 1) and 25 left eyes of 25 age matched healthy female volunteers (Group 2) were enrolled in the study.
Rajeshwari Mantgol   +2 more
core   +1 more source

Comparing the Efficacy of Platelet Rich Plasma (PRP) vs. Topical Minoxidil (5%) as Synergistic Treatment in Patients Receiving Oral Finasteride for Androgenic Alopecia

open access: yesPakistan Journal of Medical Research, 2022
Objective: To compare the efficacy of platelet rich plasma (PRP) vs. topical Minoxidil (5%) as synergistic treatments in patients receiving oral Finasteride for androgenic alopecia. Study type, settings & duration: A comparative cross sectional study
Rozeena Tumrani   +3 more
doaj   +2 more sources

Microneedle mediated transdermal delivery of β-sitosterol loaded nanostructured lipid nanoparticles for androgenic alopecia

open access: yesDrug Delivery, 2022
Plant-derived 5 α-reductase inhibitors, such as β-sitosterol and phytosterol glycosides, have been used to treat androgenic alopecia, but their oral absolute bioavailability is poor.
Kousalya Prabahar   +3 more
doaj   +1 more source

Research Trends in Telogen Effluvium From 1975 to 2025: A Bibliometric Analysis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Telogen effluvium (TE) is a common cause of diffuse hair loss. Bibliometric analyses systematically map research trends to identify influential studies and reveal knowledge gaps. Objectives To characterize research trends, influential publications, and knowledge gaps in the telogen effluvium literature through bibliometric analysis ...
Katya Peri   +5 more
wiley   +1 more source

Limited Clinical Impact of Androgen Receptor Repeat Length (CAG and GGC) in Klinefelter Syndrome: A Multivariable Analysis

open access: yesAndrology, EarlyView.
ABSTRACT Background Klinefelter syndrome (KS) is characterized by marked phenotypic heterogeneity that might be influenced by genetic modifiers, including androgen receptor (AR) repeat length (CAGn and GGCn). The clinical relevance of these repeat lengths in patients with KS before testosterone replacement therapy (TRT) remains unclear.
Andrea Graziani   +8 more
wiley   +1 more source

Hair???s Zinc Level on Androgenic Alopecia [PDF]

open access: yes, 2016
-Abstract: Androgenic alopecia is characterized by progressive loss of hair from the scalp. This research aimed to determine the hair and blood zinc levels in men with androgenic alopecia.
Farida Tabri, Farida tabri
core  

The Impact of Common Medications on Male Fertility: An Updated Systematic Review

open access: yesAndrology, EarlyView.
ABSTRACT Background Compared with those of cytotoxic treatments, the potential effects of common medications on the fertility of men trying to conceive currently or planning to conceive in the future are less well described. The use of common medications may modify the gonadotropic axis, spermatogenesis, and epididymal maturation or alter male ...
Lina Jebli   +7 more
wiley   +1 more source

Laser-assisted Hair Regrowth: Fractional Laser Modalities for the Treatment of Androgenic Alopecia

open access: yesPlastic and Reconstructive Surgery, Global Open, 2019
Background:. A large proportion of the population is at sometime affected by androgenic alopecia. Current therapies consisting of minoxidil or finasteride are often the first choices for treatment.
Robert J. Dabek, MD   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy